Apollomics Statistics
Total Valuation
Apollomics has a market cap or net worth of $37.99 million. The enterprise value is $39.18 million.
| Market Cap | 37.99M |
| Enterprise Value | 39.18M |
Important Dates
The last earnings date was Monday, November 9, 2026, after market close.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Apollomics has 2.20 million shares outstanding. The number of shares has increased by 79.73% in one year.
| Current Share Class | 2.20M |
| Shares Outstanding | 2.20M |
| Shares Change (YoY) | +79.73% |
| Shares Change (QoQ) | +62.18% |
| Owned by Insiders (%) | 70.12% |
| Owned by Institutions (%) | 0.56% |
| Float | 534,992 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 91.99 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 94.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
| Current Ratio | 0.15 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -61.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -67.41% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 79.46% |
| Weighted Average Cost of Capital (WACC) | 12.38% |
| Revenue Per Employee | $29,500 |
| Profits Per Employee | -$512,643 |
| Employee Count | 14 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Apollomics has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.00% in the last 52 weeks. The beta is 1.56, so Apollomics's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | +13.00% |
| 50-Day Moving Average | 22.76 |
| 200-Day Moving Average | 18.94 |
| Relative Strength Index (RSI) | 35.62 |
| Average Volume (20 Days) | 18,528 |
Short Selling Information
The latest short interest is 5,398, so 0.25% of the outstanding shares have been sold short.
| Short Interest | 5,398 |
| Short Previous Month | 5,730 |
| Short % of Shares Out | 0.25% |
| Short % of Float | 1.01% |
| Short Ratio (days to cover) | 0.78 |
Income Statement
In the last 12 months, Apollomics had revenue of $413,000 and -$7.18 million in losses. Loss per share was -$3.62.
| Revenue | 413,000 |
| Gross Profit | 413,000 |
| Operating Income | -7.19M |
| Pretax Income | -7.17M |
| Net Income | -7.18M |
| EBITDA | -7.17M |
| EBIT | -7.19M |
| Loss Per Share | -$3.62 |
Balance Sheet
The company has $1.01 million in cash and $2.20 million in debt, with a net cash position of -$1.19 million or -$0.54 per share.
| Cash & Cash Equivalents | 1.01M |
| Total Debt | 2.20M |
| Net Cash | -1.19M |
| Net Cash Per Share | -$0.54 |
| Equity (Book Value) | -11.15M |
| Book Value Per Share | -5.13 |
| Working Capital | -9.62M |
Cash Flow
| Operating Cash Flow | -7.04M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 21,000 |
| Net Borrowing | 1.81M |
| Free Cash Flow | -7.04M |
| FCF Per Share | -$3.21 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,740.92% |
| Pretax Margin | -1,737.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Apollomics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -79.73% |
| Shareholder Yield | -79.73% |
| Earnings Yield | -20.95% |
| FCF Yield | -18.54% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 13.12% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on November 25, 2024. It was a reverse split with a ratio of 1:100.
| Last Split Date | Nov 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |